Leading biotech companies TG Therapeutics and Twist Bioscience experienced significant declines on Monday following the release of their second-quarter reports. The stocks of these top-performing companies dropped due to mixed results. The sudden fall in value has raised concerns among investors, as these companies were previously considered top-notch in the biotech sector.